Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy

Autores de CIPF
Participantes ajenos a CIPF
- Abbott, JA
- Meyer-Schuman, R
- Feely, S
- Mademan, I
- Oprescu, SN
- Griffin, LB
- Alberti, MA
- Casasnovas, C
- Aharoni, S
- Basel-Vanagaite, L
- Zuchner, S
- De Jonghe, P
- Baets, J
- Shy, ME
- Demeler, B
- Antonellis, A
- Francklyn, C
Grupos de Investigación
Abstract
Histidyl-tRNA synthetase (HARS) ligates histidine to cognate tRNA molecules, which is required for protein translation. Mutations in HARS cause the dominant axonal peripheral neuropathy Charcot-Marie-Tooth disease type 2W (CMT2W); however, the precise molecular mechanism remains undefined. Here, we investigated three HARS missense mutations associated with CMT2W (p.Tyr330Cys, p.Ser356Asn, and p.Val155Gly). The three mutations localize to the HARS catalytic domain and failed to complement deletion of the yeast ortholog (HTS1). Enzyme kinetics, differential scanning fluorimetry (DSF), and analytical ultracentrifugation (AUC) were employed to assess the effect of these substitutions on primary aminoacylation function and overall dimeric structure. Notably, the p.Tyr330Cys, p.Ser356Asn, and p.Val155Gly HARS substitutions all led to reduced aminoacylation, providing a direct connection between CMT2W-linked HARS mutations and loss of canonical ARS function. While DSF assays revealed that only one of the variants (p.Val155Gly) was less thermally stable relative to wild-type, all three HARS mutants formed stable dimers, as measured by AUC. Our work represents the first biochemical analysis of CMT-associated HARS mutations and underscores how loss of the primary aminoacylation function can contribute to disease pathology.
Datos de la publicación
- ISSN/ISSNe:
- 1059-7794, 1098-1004
- Tipo:
- Article
- Páginas:
- 415-432
- DOI:
- 10.1002/humu.23380
- PubMed:
- 29235198
HUMAN MUTATION WILEY-BLACKWELL
Citas Recibidas en Web of Science: 27
Documentos
- No hay documentos
Filiaciones
Keywords
- aminoacyl-tRNA synthetase; Charcot-Marie-Tooth disease type 2W; hereditary motor and sensory neuropathy; histidyl-tRNA synthetase
Proyectos asociados
Neurodegeneration with Brain Iron Accumulation: Clinical Assessment and Genetic Characterization by means of a Spanish Multi-Centre Research Network
Investigador Principal: CARMEN ESPINÓS ARMERO
FUNDACION LA MARATO DE TV3 . 2015
Caracterización de MORC2, nexo de unión de neuropatías hereditarias sensitivo-motoras
Investigador Principal: CARMEN ESPINÓS ARMERO
FUNDACION RAMON ARECES . 2015
Avanzar en el diagnóstico, la prognosis y la terapia de enfermedades neurodegenerativas raras
Investigador Principal: CARMEN ESPINÓS ARMERO
INSTITUTO DE SALUD CARLOS III . 2016
De genes a terapia en enfermedades neurodegenerativas y neuromusculares. Concedido a la UV
Investigador Principal: CARMEN ESPINÓS ARMERO
CONSELLERIA DE EDUCACION . 2018